BR112022004378A2 - Vacinas para vírus lassa - Google Patents
Vacinas para vírus lassaInfo
- Publication number
- BR112022004378A2 BR112022004378A2 BR112022004378A BR112022004378A BR112022004378A2 BR 112022004378 A2 BR112022004378 A2 BR 112022004378A2 BR 112022004378 A BR112022004378 A BR 112022004378A BR 112022004378 A BR112022004378 A BR 112022004378A BR 112022004378 A2 BR112022004378 A2 BR 112022004378A2
- Authority
- BR
- Brazil
- Prior art keywords
- protein
- flavivirus
- sequence
- lassa virus
- terminus
- Prior art date
Links
- 241000712902 Lassa mammarenavirus Species 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 241000710831 Flavivirus Species 0.000 abstract 4
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 108010076504 Protein Sorting Signals Proteins 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 241000712891 Arenavirus Species 0.000 abstract 2
- 102000003886 Glycoproteins Human genes 0.000 abstract 2
- 108090000288 Glycoproteins Proteins 0.000 abstract 2
- 108700004715 Flavivirus NS1 Proteins 0.000 abstract 1
- 108091029795 Intergenic region Proteins 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 230000002238 attenuated effect Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/10011—Arenaviridae
- C12N2760/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24141—Use of virus, viral particle or viral elements as a vector
- C12N2770/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19197202 | 2019-09-13 | ||
| PCT/EP2020/075541 WO2021048402A1 (en) | 2019-09-13 | 2020-09-11 | Lassavirus vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022004378A2 true BR112022004378A2 (pt) | 2022-06-07 |
Family
ID=68137784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022004378A BR112022004378A2 (pt) | 2019-09-13 | 2020-09-11 | Vacinas para vírus lassa |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US12558410B2 (https=) |
| EP (1) | EP4041300A1 (https=) |
| JP (1) | JP7663250B2 (https=) |
| CN (1) | CN114728054A (https=) |
| AU (1) | AU2020346382A1 (https=) |
| BR (1) | BR112022004378A2 (https=) |
| WO (1) | WO2021048402A1 (https=) |
| ZA (1) | ZA202203730B (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005042014A1 (en) | 2003-10-29 | 2005-05-12 | The University Of Queensland | West nile virus vaccine |
| JP5779352B2 (ja) * | 2008-03-14 | 2015-09-16 | サノフィ パスツール バイオロジクス リミテッド ライアビリティ カンパニー | 複製欠損フラビウイルスワクチンおよびワクチンベクター |
| GB201307528D0 (en) | 2013-04-26 | 2013-06-12 | Univ Leuven Kath | Bacterial artificial chromosomes |
| BR102016018430A2 (pt) * | 2016-08-10 | 2018-02-27 | Fundação Oswaldo Cruz | Cassete de expressão heteróloga, constructo de dna e composição vacinal para imunizar contra flavivírus e/ou outros patógenos. |
| WO2019018501A1 (en) | 2017-07-18 | 2019-01-24 | Geovax Inc. | COMPOSITIONS AND METHODS FOR GENERATING LASV IMMUNE RESPONSE |
-
2020
- 2020-09-11 BR BR112022004378A patent/BR112022004378A2/pt unknown
- 2020-09-11 EP EP20767710.5A patent/EP4041300A1/en active Pending
- 2020-09-11 WO PCT/EP2020/075541 patent/WO2021048402A1/en not_active Ceased
- 2020-09-11 US US17/642,795 patent/US12558410B2/en active Active
- 2020-09-11 CN CN202080071104.5A patent/CN114728054A/zh active Pending
- 2020-09-11 JP JP2022516041A patent/JP7663250B2/ja active Active
- 2020-09-11 AU AU2020346382A patent/AU2020346382A1/en not_active Abandoned
-
2022
- 2022-03-31 ZA ZA2022/03730A patent/ZA202203730B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4041300A1 (en) | 2022-08-17 |
| CN114728054A (zh) | 2022-07-08 |
| US20220378903A1 (en) | 2022-12-01 |
| JP2022547695A (ja) | 2022-11-15 |
| ZA202203730B (en) | 2025-09-25 |
| US12558410B2 (en) | 2026-02-24 |
| JP7663250B2 (ja) | 2025-04-16 |
| AU2020346382A1 (en) | 2022-04-21 |
| WO2021048402A1 (en) | 2021-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA98620C2 (uk) | Атенуйований вірус класичної лихоманки свиней, що містить модифікований глікопротеїн е2 | |
| EP3178840A1 (en) | Heat-stable respiratory syncytial virus prefusion f protein oligomers and their use in immunological compositions | |
| JP2016501015A5 (ja) | デングウイルス血清型４（ｄｅｎ−４）構築物に関する組成物、方法および使用 | |
| HRP20220756T1 (hr) | Proteinski pripravci rsv f i postupci za izradu istih | |
| SI2506868T1 (en) | HYPER AND HYBRID POLYPETTIDES FACTOR VIII-FC AND METHODS FOR THEIR USE | |
| MX2018007860A (es) | Vacunas recombinantes contra el zika. | |
| BR112017022298A2 (pt) | geranilgeranil pirofosfato sintase | |
| PE20190352A1 (es) | Proteinas de fusion gdf 15 y usos de estas | |
| FI3539565T3 (fi) | Koostumuksia ja menetelmiä dengue-viruksen kimeerisille rakenteille rokotteissa | |
| ES2531290T3 (es) | Transferasas y oxidorreductasas, ácidos nucleicos que las codifican y métodos para prepararlas y usarlas | |
| JP2013502226A5 (https=) | ||
| DK2019864T3 (da) | Fremstilling og anvendelser af gensekvenser, der koder for kimære glykosyltransferaser med optimeret glykosyleringsaktivitet | |
| JP2016513970A5 (https=) | ||
| BR112013013548B8 (pt) | Proteína de fusão anticancerígena | |
| MX2008011728A (es) | Virus de enfermedad de newcastle recombinante que expresa hemaglutinina h5 de virus de influenza aviar. | |
| HRP20210635T1 (hr) | Novi mutant humanog seruma albumina | |
| AR105482A1 (es) | Vectores virales recombinantes que contienen la proteína menor del virus del síndrome reproductor y respiratorio porcino (prrsv) y sus métodos de elaboración y uso | |
| ES2676542T3 (es) | Composiciones de CDV recombinante y usos de las mismas | |
| RU2016145061A (ru) | Профилактическая вакцина против синдрома падения яйценоскости (eds) | |
| CN107847575A (zh) | 用于猪生殖与呼吸综合症及猪圆环病毒相关疾病的疫苗组合物 | |
| BR112018077540A2 (pt) | vírus quimérico da dengue/zika como vacinas de zika vírus vivo atenuado | |
| BR112022004378A2 (pt) | Vacinas para vírus lassa | |
| AR071534A1 (es) | Peptidos aislados que tienen actividad inhibitoria de la fosfolipasa | |
| AR072156A1 (es) | Proteinas de fusion y su aplicacion para la preparacion de vacunas contra la hepatitis c y b | |
| HRP20250701T1 (hr) | Himerni protein papiloma virusa l1 |